News

One of the things I like best about deer hunting is that you can use just about any rifle you want. For half a century, a 30-30 lever-action was the definition of a deer gun. Pumps and semi-autos ...
Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The ...
Learn more During the last quarter century, we’ve seen a tremendous advancement in rifle scopes. Some modern rifle scopes have such great glass that it seems you can almost see into the future ...
There are many things to consider when shopping for hunting gear — particularly a hunting rifle or cartridge. Gun writers like me often complicate the matter by going into molecular-level detail on ...
A Ukrainian sniper described his switch from a hunting rifle to a US-made Barrett MRAD sniper rifle. He said the US-made Barrett had a positive effect on operations. The Barrett was more accurate ...
In this article, we are going to take a look at where Sharps Technology, Inc. (NASDAQ:STSS) stands against other most active US stocks to buy according to hedge funds. Over the past five years ...
By 1972, Cahalane was also one of the Irish Republican Army’s most successful international gunrunners, ferrying rifles and bullets from Philadelphia and its suburbs to arm guerrilla fighters in ...
West Virginia claimed the overall 2025 NC rifle national team title, outscoring runner-up Kentucky. Alaska Fairbank swept the smallbore event, claiming the team smallbore title and individual ...
Over the course of the operation, authorities said they seized 400 grams of powdered cocaine; three AR-15-style assault rifles; multiple magazines and assorted ammunition; scales and drug packaging ...
Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www ...
Short interest in Sharps Technology Inc (NASDAQ:STSS) increased during the last reporting period, rising from 1.06M to 2.70M. This put 49.63% of the company's publicly available shares short.